文献速递冠心病

临时支架与双支架策略治疗分叉病变的长期结局:随机试验荟萃分析

Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
PubMed 文献 · Heart · 2017-03-17

该荟萃分析纳入8项随机对照试验共2778例分叉病变患者,比较临时支架(PS)与双支架(TS)策略的长期结局。平均随访3.0±1.6年,PS与全因死亡风险降低相关(RR=0.66),主要不良心脏事件、心肌梗死、靶病变血运重建及支架血栓风险无显著差异。敏感性分析(随访≥3年)中PS与全因死亡、主要不良心脏事件及心肌梗死风险降低相关。

要点

  • 平均随访3.0±1.6年,PS较TS降低全因死亡风险(RR=0.66)。
  • PS与TS在主要不良心脏事件、心肌梗死、靶病变血运重建及支架血栓风险无显著差异。
  • 随访≥3年的试验中,PS较TS降低全因死亡、主要不良心脏事件及心肌梗死风险。

核心结论

  • 对于冠状动脉分叉病变,临时支架策略可能较双支架策略带来长期死亡获益。

研究设计与样本

  • 研究为随机对照试验的荟萃分析,检索截至2016年8月的在线数据库,纳入报告随访≥1年结局的随机对照试验,共8项试验、2778例患者。

主要发现

  • 平均随访3.0±1.6年,临时支架组较双支架组全因死亡风险降低(RR=0.66;95% CI 0.45至0.98;p=0.04)。
  • 临时支架组与双支架组在主要不良心脏事件、心肌梗死、靶病变血运重建及支架血栓风险方面无显著差异。
  • 敏感性分析限随访≥3年的试验(平均随访4.6±0.7年),临时支架组较双支架组全因死亡风险降低(RR=0.57;95% CI 0.36至0.88;p=0.01)、主要不良心脏事件风险降低(RR=0.71;95% CI 0.52至0.97;p=0.03)及心肌梗死风险降低(RR=0.45;95% CI 0.21至0.96;p=0.04)。
  • 敏感性分析中,临时支架组与双支架组靶病变血运重建风险(RR=0.81;95% CI 0.57至1.15;p=0.24)及支架血栓风险(RR=0.75;95% CI 0.19至2.84;p=0.67)仍相似。
  • 荟萃回归分析发现,在急性冠脉综合征患者中,临时支架策略与主要不良心脏事件风险增加相关(p=0.05)。

临床怎么用

  • 原文结论指出,对于冠状动脉分叉病变,临时支架策略可能较双支架策略带来长期死亡获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal interventional technique for addressing coronary bifurcation lesions is debatable. Long-term clinical outcomes with provisional stenting (PS) compared with a two-stent (TS) strategy for bifurcation lesions are scarce. We aim to perform the first meta-analysis of randomised controlled trials (RCTs) to explore long-term outcomes comparing both strategies. METHODS: An electronic search was performed for online databases until August 2016 for RCTs comparing PS with TS for bifurcation lesions reporting outcomes at 1 year of follow-up or more. Random effects model risk ratios (RRs) were calculated for outcomes of interest. RESULTS: Eight RCTs with a total of 2778 patients reported long-term clinical outcomes. At mean follow-up of 3.0±1.6 years, PS was associated with lower risk of all-cause mortality (RR=0.66; 95% CI 0.45 to 0.98; p=0.04) compared with TS for bifurcation lesions. No difference was observed with PS compared with TS regarding major adverse cardiac events (MACE), myocardial infarction (MI), target lesion revascularisation (TLR) or stent thrombosis (ST). In a sensitivity analysis limited to trials with follow-up duration ≥3 years, PS was associated with lower risk of all-cause mortality (RR=0.57; 95% CI 0.36 to 0.88; p=0.01), MACE (RR=0.71; 95% CI 0.52 to 0.97; p=0.03) and MI (RR=0.45; 95% CI 0.21 to 0.96; p=0.04) compared with TS, at mean follow-up of 4.6±0.7 years. The risk of TLR and ST remained similar with both strategies (RR=0.81; 95% CI 0.57 to 1.15; p=0.24; and RR=0.75; 95% CI 0.19 to 2.84; p=0.67 respectively). Meta-regression analyses identified increased risk of MACE with PS in patients presenting with acute coronary syndrome (p=0.05). CONCLUSION: PS may be associated with a long-term mortality benefit compared with a TS strategy for coronary bifurcation lesions.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Nairooz R, Saad M, Elgendy IY, et al. Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials. Heart. 2017. PMID: 28314731. doi:10.1136/heartjnl-2016-310929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。